1. ScholarBank@NUS

Wee Han Ang

rp02574

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Han Ang
Variants
Ang, W.H.
Ang, Wee Han
 
Main Affiliation
 
Faculty
 
Email
chmawh@nus.edu.sg
 
Other emails
 

Publications

Results 21-35 of 35 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
21Jan-2014P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cellsTay, Z.; Koo, S.H.; Nguyen, T.T.T.; Tan, T.S.; Chen, M.L.; Chin, C.F.; Lim, K.K.; Ang, W.H. ; Bay, B.H.; Lee, E.J.D.; Chen, E.S. 
222015Platinum(IV) carboxylate prodrug complexes as versatile platforms for targeted chemotherapyOng, Jun Xiang ; Yap, Siew Qi; Wong, Daniel Yuan Qiang; Chin, Chee Fei; Ang, Wee Han 
23Jun-2012Platinum(iv) prodrugs entrapped within multiwalled carbon nanotubes: Selective release by chemical reduction and hydrophobicity reversalLi, J. ; Yap, S.Q.; Chin, C.F.; Tian, Q. ; Yoong, S.L.; Pastorin, G. ; Ang, W.H. 
421-Jan-2016Predicting chemotherapeutic drug combinations through gene network profilingNguyen, Thi Thuy Trang ; Chua, Jacqueline Kia Kee; Seah, Kwi Shan ; Koo, Seok Hwee ; Yee, Jie Yin; Yang, Eugene Guorong ; Lim, Kim Kiat ; Pang, Shermaine Yu Wen; Yuen, Audrey; Zhang, Louxin ; Ang, Wee Han ; Dymock, Brian ; Lee, Edmund Jon Deoon ; Chen, Ee Sin 
52014Ratiometric delivery of cisplatin and doxorubicin using tumour-targeting carbon-nanotubes entrapping platinum(iv) prodrugsChin, C.F.; Yap, S.Q.; Li, J. ; Pastorin, G.; Ang, W.H. 
619-Nov-2012Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1BOng, J.X.; Yap, C.W. ; Ang, W.H. 
72016Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistanceChow, M.J ; Licona, C; Pastorin, G ; Mellitzer, G; Ang, W.H ; Gaiddon, C
84-Jul-2011Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activationParker, L.J.; Italiano, L.C.; Morton, C.J.; Hancock, N.C.; Ascher, D.B.; Aitken, J.B.; Harris, H.H.; Campomanes, P.; Rothlisberger, U.; De Luca, A.; Lo Bello, M.; Ang, W.H. ; Dyson, P.J.; Parker, M.W.
92007Sulfonium-based ionic liquids incorporating the allyl functionalityZhao, D; Fei, Z; Wee, H.A ; Dyson, P.J
102011Synthesis of fullerene@gold core-shell nanostructuresRen, Y.; Paira, P. ; Nayak, T.R.; Ang, W.H. ; Pastorin, G. 
11Feb-2023Targeting emerging cancer hallmarks by transition metal complexes: Cancer stem cells and tumor microbiome. Part IChang, Meng Rui; Rusanov, Daniil A; Arakelyan, Jemma; Alshehri, Mana; Asaturova, Aleksandra V; Kireeva, Galina S; Babak, Maria V; Ang, Wee Han 
1215-Jan-2023Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part IIArakelyan, J; Rusanov, DA; Chang, MR; Asaturova, AV; Kireeva, GS; Alshehri, M; Ang, WH ; Babak, MV
132012Transcription inhibition by organometallic rutheniumarene anticancer complexes in live mammalian cellsAstarina, A.; Chow, M.J.; Ang, W.H. 
142020Triapine derivatives act as copper delivery vehicles to induce deadly metal overload in cancer cellsOhui, K.; Stepanenko, I.; Besleaga, I.; Babak, M.V. ; Stafi, R.; Darvasiova, D.; Giester, G.; Pósa, V.; Enyedy, E.A.; Vegh, D.; Rapta, P.; Ang, W.H. ; Popovi?-Bijeli?, A.; Arion, V.B.
1513-Sep-2012Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylationChin, C.F.; Tian, Q. ; Setyawati, M.I.; Fang, W. ; Tan, E.S.Q. ; Leong, D.T. ; Ang, W.H.